C. Lucchinetti, W. Brück, J. Parisi, B. Scheithauer, M. Rodriguez et al., Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination, Annals of Neurology, vol.47, issue.6, pp.707-717, 2000.

A. Compston and A. Coles, Multiple sclerosis, The Lancet, vol.372, issue.9648, pp.1502-1517, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00996686

B. Bahbouhi, S. Pettré, and L. Berthelot, T cell recognition of self-antigen presenting cells by protein transfer assay reveals a high frequency of anti-myelin T cells in multiple sclerosis, Brain, vol.133, issue.6, pp.1622-1636, 2010.

A. Ben-nun, H. Wekerle, and I. R. Cohen, Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein, Nature, vol.292, issue.5818, pp.60-61, 1981.

H. Wekerle, Lessons from multiple sclerosis: models, concepts, observations, Annals of the Rheumatic Diseases, vol.67, pp.56-60, 2008.

A. G. Baxter, The origin and application of experimental autoimmune encephalomyelitis, Nature Reviews Immunology, vol.7, issue.11, pp.904-912, 2007.

A. E. Ngono, S. Pettré, and M. Salou, Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients, Clinical Immunology, vol.144, issue.2, pp.117-126, 2012.

M. Krumbholz, T. Derfuss, R. Hohlfeld, and E. Meinl, B cells and antibodies in multiple sclerosis pathogenesis and therapy, Nature Reviews Neurology, vol.8, issue.11, pp.613-623, 2012.

M. Reindl, F. D. Pauli, K. Rostásy, and T. Berger, The spectrum of MOG autoantibody-associated demyelinating diseases, Nature Reviews Neurology, vol.9, issue.8, pp.455-461, 2013.

S. L. Hauser, E. Waubant, and D. L. Arnold, B-cell depletion with rituximab in relapsing-remitting multiple sclerosis, The New England Journal of Medicine, vol.358, issue.7, pp.676-688, 2008.

E. G. Kamburova, H. J. Koenen, K. J. Borgman, I. J. Berge, I. Joosten et al., A single dose of rituximab does not deplete b cells in secondary lymphoid organs but alters phenotype and function, American Journal of Transplantation, vol.13, issue.6, pp.1503-1511, 2013.

C. T. Harp, S. Ireland, and L. S. Davis, Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4

+. , cell proliferation and IFN-production in response to myelin basic protein and myelin oligodendrocyte glycoprotein, European Journal of Immunology, vol.40, issue.10, pp.2942-2956, 2010.

C. Mauri and A. Bosma, Immune regulatory function of B cells, Annual Review of Immunology, vol.30, pp.221-241, 2012.

S. Fillatreau, C. H. Sweenie, M. J. Mcgeachy, D. Gray, and S. M. Anderton, B cells regulate autoimmunity by provision of IL-10, Nature Immunology, vol.3, issue.10, pp.944-950, 2002.

L. Le-texier, P. Thebault, and A. Lavault, Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile, The American Journal of Transplantation, vol.11, issue.3, pp.429-438, 2011.

M. Chesneau, A. Pallier, and F. Braza, Unique B cell differentiation profile in tolerant kidney transplant patients, The American Journal of Transplantation, vol.14, issue.1, pp.144-155, 2014.
DOI : 10.1111/ajt.12508

URL : https://hal.archives-ouvertes.fr/hal-00974748

S. Knippenberg, E. Peelen, and J. Smolders, Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission, Journal of Neuroimmunology, vol.239, issue.1-2, pp.80-86, 2011.

Y. Iwata, T. Matsushita, and M. Horikawa, Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells, Blood, vol.117, issue.2, pp.530-541, 2011.

H. Wardemann, S. Yurasov, A. Schaefer, J. W. Young, E. Meffre et al., Predominant autoantibody production by early human B cell precursors, Science, vol.301, issue.5638, pp.1374-1377, 2003.
DOI : 10.1126/science.1086907

E. Meffre and H. Wardemann, B-cell tolerance checkpoints in health and autoimmunity, Current Opinion in Immunology, vol.20, issue.6, pp.632-638, 2008.

N. Degauque, A. E. Ngono, and A. , Characterization of antigen-specific B cells using nominal antigen-coated flowbeads, Article ID e84273, vol.8, issue.12, 2013.

K. Raddassi, S. C. Kent, and J. Yang, Increased frequencies of myelin oligodendrocyte glycoprotein/MHC class IIbinding CD4 cells in patients with multiple sclerosis, Journal of Immunology, vol.187, issue.2, pp.1039-1046, 2011.

C. H. Polman, S. C. Reingold, and G. Edan, Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald Criteria, Annals of Neurology, vol.58, issue.6, pp.840-846, 2005.

C. Breithaupt, B. Schäfer, H. Pellkofer, R. Huber, C. Linington et al., Demyelinating myelin oligodendrocyte glycoprotein-specific autoantibody response is focused on one dominant conformational epitope region in rodents, Journal of Immunology, vol.181, issue.2, pp.1255-1263, 2008.

B. B. Weksler, E. A. Subileau, and N. Perrière, Blood-brain barrier-specific properties of a human adult brain endothelial cell line, The FASEB Journal, vol.19, issue.13, pp.1872-1874, 2005.

B. Bahbouhi, L. Berthelot, and S. Pettré, Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line, Journal of Leukocyte Biology, vol.86, issue.5, pp.1049-1063, 2009.

F. Pauli, S. Mader, and K. Rostasy, Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases, Clinical Immunology, vol.138, issue.3, pp.247-254, 2011.

T. Litzenburger, R. Fässler, and J. Bauer, B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice, Journal of Experimental Medicine, vol.188, issue.1, pp.169-180, 1998.

D. Lee and R. A. Linker, The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?, Expert Opinion on Therapeutic Targets, vol.16, issue.5, pp.451-462, 2012.

I. J. Amanna, N. E. Carlson, and M. K. Slifka, Duration of humoral immunity to common viral and vaccine antigens, The New England Journal of Medicine, vol.357, issue.19, pp.1903-1915, 2007.

U. Klein, K. Rajewsky, and R. Küppers, Human immunoglobulin (Ig)M + IgD + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells, The Journal of Experimental Medicine, vol.188, issue.9, pp.1679-1689, 1998.

A. L. Peters, L. L. Stunz, and G. A. Bishop, CD40 and autoimmunity: the dark side of a great activator, Seminars in Immunology, vol.21, issue.5, pp.293-300, 2009.

J. Gerdes, U. Schwab, H. Lemke, and H. Stein, Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation, International Journal of Cancer, vol.31, issue.1, pp.13-20, 1983.

A. Alter, M. Duddy, and S. Hebert, Determinants of human B cell migration across brain endothelial cells, Journal of Immunology, vol.170, issue.9, pp.4497-4505, 2003.

R. A. Farrell, D. Antony, and G. R. Wall, Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI, Neurology, vol.73, issue.1, pp.32-38, 2009.

L. I. Levin, K. L. Munger, and M. V. Rubertone, Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis, The Journal of the American Medical Association, vol.293, issue.20, pp.2496-2500, 2005.

C. Linington, T. Berger, and L. Perry, T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system, European Journal of Immunology, vol.23, issue.6, pp.1364-1372, 1993.

N. Baumann and D. Pham-dinh, Biology of oligodendrocyte and myelin in the mammalian central nervous system, Physiological Reviews, vol.81, issue.2, pp.871-927, 2001.

H. Von-büdingen, S. L. Hauser, J. Ouallet, N. Tanuma, T. Menge et al., Frontline: epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination, European Journal of Immunology, vol.34, issue.8, pp.2072-2083, 2004.

S. J. Pittock, M. Reindl, and S. Achenbach, Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: Frequency, stability and clinicopathologic correlations, Multiple Sclerosis Journal, vol.13, issue.1, pp.7-16, 2007.

C. A. Muniz-caldas and J. Freire-de-carvalho, The role of environmental factors in the pathogenesis of non-organspecific autoimmune diseases, Best Practice and Research, vol.26, issue.1, pp.5-11, 2012.

G. R. Persson, Rheumatoid arthritis and periodontitisinflammatory and infectious connections, Journal of Oral Microbiology, vol.4, 2012.

P. O. Barros, U. C. Linhares, and B. Teixeira, High in vitro immune reactivity to Escherichia coli in neuromyelitis optica patients is correlated with both neurological disabilities and elevated plasma lipopolysaccharide levels, Human Immunology, vol.74, issue.9, pp.1080-1087, 2013.

S. Ferrari-lacraz, J. Tiercy, and J. Villard, Detection of anti-HLA antibodies by solid-phase assay in kidney transplantation: friend or foe?, Tissue Antigens, vol.79, issue.5, pp.315-325, 2012.

D. O. Griffin and T. L. Rothstein, Human B1 cell frequency: isolation and analysis of human B1 cells, Frontiers in Immunology, vol.3, p.122, 2012.

C. Tørring, C. C. Petersen, L. Bjerg, E. Kofod-olsen, T. Petersen et al., The B1-cell subpopulation is diminished in patients with relapsing-remitting multiple sclerosis, Journal of Neuroimmunology, vol.262, issue.1-2, pp.92-99, 2013.

T. Kinnunen, N. Chamberlain, and H. Morbach, Specific peripheral B cell tolerance defects in patients with multiple sclerosis, Journal of Clinical Investigation, vol.123, issue.6, pp.2737-2741, 2013.

S. Kuerten, G. Pommerschein, and S. K. Barth, Identification of a B cell-dependent subpopulation of multiple sclerosis by measurements of brain-reactive B cells in the blood, Clinical Immunology, vol.152, issue.1-2, pp.20-24, 2014.

M. Markovic, V. Trajkovic, and J. Drulovic, Antibodies against myelin oligodendrocyte glycoprotein in the cerebrospinal fluid of multiple sclerosis patients, Journal of the Neurological Sciences, vol.211, issue.1-2, pp.67-73, 2003.

H. Von-büdingen, T. C. Kuo, and M. Sirota, B cell exchange across the blood-brain barrier in multiple sclerosis, Journal of Clinical Investigation, vol.122, issue.12, pp.4533-4543, 2012.

A. Palanichamy, L. Apeltsin, and T. C. Kuo, Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis, Science Translational Medicine, vol.6, issue.248, pp.248-106, 2014.

B. Melchior, V. Nérrière-daguin, and N. Degauque, Compartmentalization of TCR repertoire alteration during rejection of an intrabrain xenograft, Experimental Neurology, vol.192, issue.2, pp.373-383, 2005.

J. J. Iliff, M. Wang, and Y. Liao, A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid, Science Translational Medicine, vol.4, issue.147, 2012.

L. Yang, B. T. Kress, and H. J. Weber, Evaluating glymphatic pathway function utilizing clinically relevant intrathecal infusion of CSF tracer, Journal of Translational Medicine, vol.11, issue.1, p.107, 2013.

N. Molnarfi, U. Schulze-topphoff, and M. S. Weber, MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies, Journal of Experimental Medicine, vol.210, issue.13, pp.2921-2937, 2013.

P. Shen, T. Roch, and V. Lampropoulou, IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases, Nature, vol.507, issue.7492, pp.366-370, 2014.